Expediting the availability of drugs for US patients with cancer
Nat Clin Pract Urol
.
2008 Dec;5(12):654-6.
doi: 10.1038/ncpuro1255.
Authors
Ann T Farrell
1
,
Richard Pazdur
,
Andrew C von Eschenbach
Affiliation
1
Division of Drug Oncology Products, US Food and Drug Administration, Rockville, MD 20847, USA.
PMID:
19050708
DOI:
10.1038/ncpuro1255
No abstract available
Publication types
Review
MeSH terms
Antineoplastic Agents / therapeutic use*
Drug Approval / methods*
Humans
Neoplasms / drug therapy*
Neoplasms / epidemiology
United States / epidemiology
Substances
Antineoplastic Agents